Pharmacology of Calcium Channel Blockers Flashcards
Describe the role of Calcium (Ca2+) in cardiac pacemaker cells:
-sinoatrial (SA) node is the pacemaker of the heart
-Ca2+ enters through calcium channels in the SA node allowing for the development of action potential (AP)
-Ca2+ influx in conduction tissues (including AV node) -> propagates electrical impulses -> excitation linked with myocyte contraction
Describe the role of Calcium (Ca2+) in cardiac muscle cells (myocytes):
-during phase II action potential (AP), Ca2+ enters through voltage gated L-type calcium channels
-release of Ca2+ from sarcoplasmic reticulum through the ryanodine receptor (RyR) complexes
-Ca2+ binds to troponin C
-CONTRACTION (force of contraction is dependent on the total amount of calcium
Describe the role of Calcium (Ca2+) in vascular smooth muscle:
-Ca2+ enters the cell through L-type calcium channels
-vascular smooth muscle contraction
clinical hypertension due to enhanced peripheral vasoconstriction
What chemical drives the actin-myosin contraction?
calcium (Ca2+)
Where do all Calcium Channel Blockers bind on L-type receptors?
alpha1 subunit (helps form the transmembrane channel)
What is the cause of hypertension?
changes in calcium channel function and/or increased calcium channel density
Describe : Timothy Syndrome 1 (TS1)
gain of function mutation in Ca 1.2 alpha subunit of the voltage-dependent L-type cardiac calcium channel that results in prolonged channel opening
What are the general effects of blocking Ca2+ by calcium channel blockers (CCBs)?
-vasodilation
-negative inotropy (decreased force of contraction)
-negative chronotropy (decreased HR)
-negative dromotropy (decreased conduction velocity in the heart and AV)
Where is the binding site of Nifedipine?
N-site
Where is the binding site of Verapamil?
V-site
Where is the binding site of Diltiazem?
D-site
What are the general approved used of calcium channel blockers (CCBs)?
-hypertension
-angina and coronary vasospasms
-supraventricular arrhythmias (rapid HR)
What drugs are 1,4-Dihydropyridines?
-nifedipine (1st gen)
-nicardipine (2nd gen)
-amlodipine (3rd gen)
many others
What is the MOA of 1,4-Dihydropyridines?
in general, provides dose-dependent voltage gated L-type calcium channel block with greater selectivity in vascular smooth muscle by binding inactive calcium channels. THEY ARE PREDOMINANTLY PERIPHERAL ARTERIAL VASODILATORS. they will also work on coronary arteries by vasodilating (decrease in arterial BP), reducing resistance, increasing blood flow.
What is the main use of 1,4-Dihydropyridines?
hypertension, but also angina